The authors identified antibodies to six TMP and TMOD epitopes that had sensitivity ≥63% and specificity ≥80% for stage 1–2 and US-negative endometriosis; these parameters did not differ significantly in the follicular and luteal phases of the menstrual cycle. The gene discussed is TMOD1; the disease is endometriosis.